145 results on '"Martina, Byron E. E."'
Search Results
2. Cationic Geminoid Peptide Amphiphiles Inhibit DENV2 Protease, Furin, and Viral Replication
3. Continued Circulation of Tick-Borne Encephalitis Virus Variants and Detection of Novel Transmission Foci, the Netherlands.
4. Defining Efficacy of Chikungunya Virus Candidate Vaccines: Different Endpoints Derived From the Virus—Cytokine—Ferritin (VCF) Model
5. Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7
6. Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72
7. Zika Virus Outbreak on Curaçao and Bonaire, a Report Based on Laboratory Diagnostics Data
8. SARS virus infection of cats and ferrets
9. Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
10. Zika Virus Infection Induces Elevation of Tissue Factor Production and Apoptosis on Human Umbilical Vein Endothelial Cells
11. Analysis of Mouse Brain Transcriptome After Experimental Duvenhage Virus Infection Shows Activation of Innate Immune Response and Pyroptotic Cell Death Pathway
12. Phenotypic Differences between Asian and African Lineage Zika Viruses in Human Neural Progenitor Cells
13. Transcriptomic Analyses Reveal Differential Gene Expression of Immune and Cell Death Pathways in the Brains of Mice Infected with West Nile Virus and Chikungunya Virus
14. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice
15. Neurotropic virus infections as the cause of immediate and delayed neuropathology
16. Dengue Virus Infection in Humans: Epidemiology, Biology, Pathogenesis, and Clinical Aspects
17. Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release
18. Time since Onset of Disease and Individual Clinical Markers Associate with Transcriptional Changes in Uncomplicated Dengue
19. Bioinformatics in New Generation Flavivirus Vaccines
20. Hyperferritinaemia in Dengue Virus Infected Patients Is Associated with Immune Activation and Coagulation Disturbances
21. Pathology of experimental SARS coronavirus infection in cats and ferrets
22. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
23. Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge
24. Susceptibility of European jackdaws (Corvus monedula) to experimental infection with lineage 1 and 2 West Nile viruses
25. Characterization of the Mouse Neuroinvasiveness of Selected European Strains of West Nile Virus
26. Characterization of Synthetic Chikungunya Viruses Based on the Consensus Sequence of Recent E1-226V Isolates
27. Microbial Translocation Is Associated with Extensive Immune Activation in Dengue Virus Infected Patients with Severe Disease
28. In Vitro and in Vivo Evaluation of Mutations in the NSW Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model.
29. In Vitro and In Vivo Isolation and Characterization of Duvenhage Virus
30. Evaluation of the 2009 WHO Dengue Case Classification in an Indonesian Pediatric Cohort
31. A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus
32. Plasma Levels of Inter-α Inhibitor Proteins in Children with Acute Dengue Virus Infection
33. Dengue Virus Pathogenesis: an Integrated View
34. Virology: SARS virus infection of cats and ferrets
35. Prevalence of Antibodies against Canine Distemper Virus among Red Foxes in Luxembourg
36. Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets.
37. West Nile Virus: Immunity and Pathogenesis.
38. A VLP-based vaccine targeting domain III of theWest Nile virus E protein protects from lethalinfection in mice.
39. Cowpox virus transmission from rats to monkeys, the Netherlands.
40. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.
41. Inhibition of caspase-1 prolongs survival of mice infected with rabies virus.
42. Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus.
43. Characterization of antibody response in patients with acute and chronic chikungunya virus disease.
44. Hyperferritinemia is a potential marker of chronic chikungunya: A retrospective study on the Island of Curaçao during the 2014-2015 outbreak.
45. Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008-2012 and 2014.
46. Markers of endothelial cell activation and immune activation are increased in patients with severe leptospirosis and associated with disease severity.
47. Susceptibility of Carrion Crows to Experimental Infection with Lineage 1 and 2 West Nile Viruses.
48. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
49. Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection.
50. Dengue pathogenesis: a disease driven by the host response.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.